“The U.S. logged more than 170,000 newly reported Covid-19 cases for the second time, as the death toll crossed the quarter-million mark,” WSJ writes.
Numbers To Consider:
- U.S. Total Cases: 11,500,000
- U.S. Daily Cases: 170,161
- Total U.S. Hospitalizations: 79,410
- Patients in Intensive Care Units: 15,350
- U.S. Death Toll: 250,000
Other Important Details:
- Wednesday’s more than 170,000 new cases were the second-highest daily case count after the country reported 177,224 new infections on Friday.
- New York City, the nation’s largest school district, announced schools “would temporarily close Thursday, at least through the end of the month.”
- States such as Kentucky, Minnesota, Wisconsin and Illinois enacted a patch of new restrictions — mask mandates, bar and restaurant shutdowns and limits on private gatherings — to combat the virus’s spread.
- Covid-19 has surpassed more than 56 million infections worldwide and resulted in nearly 1.35 million deaths.
- Oxford and AstraZeneca’s experimental Covid-19 vaccine doesn’t have efficacy data yet, but “showed promising immune responses in elderly and older adults.
Data courtesy of Johns Hopkins University and the Covid Tracking Project.
It is looking like the Pfizer / BioNTech ($PFE, $BNTX) and Moderna ($MRNA) vaccines will be distributed at the start of 2021, providing hope for recovery.
But given that both vaccines have logistical storage challenges, are very painful to take, and require two doses, I am concerned that the population won’t start taking vaccines until well into 2021.
Until then, this winter is looking like it will be bad for both cases and deaths. We’ll have to prepare for a very choppy ride, both in life and in the markets.